Status:
UNKNOWN
Expression of CXCR4 in Patients With Systemic Lupus Erythematosus
Lead Sponsor:
Sohag University
Conditions:
Systemic Lupus Erythematosus
Eligibility:
All Genders
16-60 years
Brief Summary
The objective of this study is to estimate the possible role of CD184 in the pathogenesis of SLE; comparing its level among SLE cases to healthy controls.
Detailed Description
Detection of CXCR4 (CD184) expression on CD19+ B cells by flow cytometry in patients of SLE, comparing its level in the development of lupus activity and pathogenic process of SLE internal organ invol...
Eligibility Criteria
Inclusion
- Confirmed SLE patients diagnosed and fulfilled the SLE classification criteria according to the 2019 ACR/EULAR classification criteria for SLE (Aringer et al., 2019)
- Willing and agreed to be included in the study.
Exclusion
- Childhood SLE.
- SLE-patients will refuse to consent to this study.
- Other autoimmune diseases.
- Known or suspected malignancies, especially B cell lymphoma.
Key Trial Info
Start Date :
May 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04799730
Start Date
May 1 2021
End Date
May 1 2022
Last Update
March 16 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.